PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The Medical University of South Carolina will be one of four sites exploring the genetic basis of Parkinson’s disease in the Black community

The Medical University of South Carolina  will be one of four sites exploring the genetic basis of Parkinson’s disease in the Black community
2024-02-07
(Press-News.org) The Michael J. Fox Foundation for Parkinson’s Research has chosen MUSC as one of four sites for the Black and African American Connections to Parkinson’s Disease (BLAAC PD) research study, a part of the Global Parkinson’s Genetics Program.

BLAAC PD will explore the genetic basis of Parkinson’s disease (PD) in the Black community by genotyping more than 150,000 people worldwide, setting the stage for the development of targeted treatments. According to the Parkinson’s Foundation, approximately 36,265 people with PD live in North Carolina and South Carolina.

Vanessa Hinson, M.D., Ph.D., director of the Parkinson’s Disease Foundation Center of Excellence at MUSC, will be the principal investigator for the MUSC site of the BLAAC PD study.

“When this opportunity came about for BLAAC PD to specifically look at and serve the Black and African American population, I thought that this was something our state should be doing, given that about 26.3% of South Carolinians are of that ancestry,” she said.

Studies have shown that PD can manifest in various ways due to differences in genetic mutations and subtypes. Specifically, people of African ancestry displayed a mutation that quadruples the risk of getting PD and is not seen in people of European ancestry. Delivering treatments that are specific to this subtype of PD could improve these patients’ outcomes.

“If we could undo what goes wrong in a person's brain who has such a gene by delivering a targeted treatment to that particular gene mechanism, then we would potentially be able to halt the progression or reverse the Parkinson's issue directly,” she said.

The mutation that has already been identified in people of African ancestry is associated with a higher risk for cognitive impairment in PD. This novel finding creates a pathway for equity by laying the scientific foundation for targeted treatments that could improve cognition and memory for patients with PD in the Black community. BLAAC PD will also continue to look for other mutations implicated in PD in the Black population.

Hinson is proud that MUSC will be a site for BLAAC PD because she believes it will build community and create awareness of Parkinson’s disease research in Black and African American communities. To get the word out about the study, she will work with community champions as well as primary care providers statewide who are affiliated with MUSC Health’s Regional Health Network.

“It's about building trust and making sure people understand that MUSC is accessible,” explained Hinson.

# # #

About MUSC

Founded in 1824 in Charleston, MUSC is the state’s only comprehensive academic health system, with a unique mission to preserve and optimize human life in South Carolina through education, research and patient care. Each year, MUSC educates more than 3,200 students in six colleges – Dental Medicine, Graduate Studies, Health Professions, Medicine, Nursing and Pharmacy – and trains more than 900 residents and fellows in its health system. MUSC brought in more than $298 million in research funds in fiscal year 2022, leading the state overall in research funding. MUSC also leads the state in federal and National Institutes of Health funding, with more than $220 million. For information on academic programs, visit musc.edu.

As the health care system of the Medical University of South Carolina, MUSC Health is dedicated to delivering the highest-quality and safest patient care while educating and training generations of outstanding health care providers and leaders to serve the people of South Carolina and beyond. Patient care is provided at 16 hospitals (includes owned and equity stake), with approximately 2,700 beds and four additional hospital locations in development; more than 350 telehealth sites and connectivity to patients’ homes; and nearly 750 care locations situated in all regions of South Carolina. In 2022, for the eighth consecutive year, U.S. News & World Report named MUSC Health University Medical Center in Charleston the No. 1 hospital in South Carolina. To learn more about clinical patient services, visit muschealth.org.

MUSC has a total enterprise annual operating budget of $5.1 billion. The nearly 26,000 MUSC family members include world-class faculty, physicians, specialty providers, scientists, students, affiliates and care team members who deliver groundbreaking education, research, and patient care.

END

[Attachments] See images for this press release:
The Medical University of South Carolina  will be one of four sites exploring the genetic basis of Parkinson’s disease in the Black community The Medical University of South Carolina  will be one of four sites exploring the genetic basis of Parkinson’s disease in the Black community 2

ELSE PRESS RELEASES FROM THIS DATE:

ORNL's Jason DeGraw named ASHRAE Fellow

ORNLs Jason DeGraw named ASHRAE Fellow
2024-02-07
The American Society of Heating, Refrigeration and Air-Conditioning Engineers, or ASHRAE, selected Jason DeGraw, a researcher with the Department of Energy’s Oak Ridge National Laboratory, as one of 23 members elevated to Fellow during its 2024 winter conference. A thermal-fluid scientist and mechanical engineer in the Thermal Energy Storage group, DeGraw was recognized for making substantial contributions in heating, ventilation, air-conditioning and refrigeration, and the built environment. He contributes education, research, engineering design and consultation, publications, presentations and mentoring to ASHRAE. At ORNL, DeGraw works with the Building Technologies ...

Sara Federico, MD, named director of the Solid Tumor Division at St. Jude Children’s Research Hospital

Sara Federico, MD, named director of the Solid Tumor Division at St. Jude Children’s Research Hospital
2024-02-07
(Memphis, Tenn. – February 7, 2024) St. Jude Children’s Research Hospital today announced Sara M. Federico, MD, has been named director of the institution’s Solid Tumor Division within the Department of Oncology. Federico is an internationally recognized leader in pediatric oncology whose contributions have defined the landscape of treatment for high-risk childhood solid tumors, such as neuroblastoma. “Dr. Federico’s experience will pave the way for new discoveries that will help advance cure rates for patients with high-risk cancers by identifying, testing and optimizing novel therapeutic strategies,” said Julie R. ...

Cancer researcher Craig B. Thompson named 2024 Watanabe Prize winner

Cancer researcher Craig B. Thompson named 2024 Watanabe Prize winner
2024-02-07
INDIANAPOLIS – Pioneering cancer researcher Craig B. Thompson, MD, has been named the 2024 winner of the August M. Watanabe Prize in Translational Research. Awarded by the Indiana University School of Medicine, the Watanabe Prize is one of the nation's largest and most prestigious awards recognizing individuals focused on shepherding scientific discoveries into new therapies for patients. The prize is awarded to a senior investigator who has made a significant contribution to the field of translational science.  Thompson is the former president and chief executive officer ...

Chapman scientists code ChatGPT to design new medicine

2024-02-07
Generative artificial intelligence platforms, from ChatGPT to Midjourney, grabbed headlines in 2023. But GenAI can do more than create collaged images and help write emails — it can also design new drugs to treat disease. Today, scientists use advanced technology to design new synthetic drug compounds with the right properties and characteristics, also known as “de novo drug design.” However, current methods can be labor-, time-, and cost-intensive. Inspired by ChatGPT’s popularity and wondering if this approach could speed up the drug design process, scientists in the Schmid ...

Erectile dysfunction drugs may be linked to reduced risk of Alzheimer’s disease

2024-02-07
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, FEBRUARY 7, 2024 MINNEAPOLIS – The drugs used to treat erectile dysfunction may also be associated with a reduced risk of Alzheimer’s disease, according to a study published in the February 7, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that erectile dysfunction drugs reduce the risk of Alzheimer’s disease. It only shows an association. Erectile dysfunction drugs, which work by dilating blood vessels to allow more blood ...

Q&A: Helping robots identify objects in cluttered spaces

Q&A: Helping robots identify objects in cluttered spaces
2024-02-07
Imagine a coffee cup sitting on a table. Now, imagine a book partially obscuring the cup. As humans, we still know what the coffee cup is even though we can't see all of it. But a robot might be confused.  Robots in warehouses and even around our houses struggle to identify and pick up objects if they are too close together, or if a space is cluttered. This is because robots lack what psychologists call "object unity," or our ability to identify things even when we can't see all of them. Researchers at the University of Washington ...

Evaluation of ruxolitinib, a Janus Kinase inhibitor, in multiple myeloma

Evaluation of ruxolitinib, a Janus Kinase inhibitor, in multiple myeloma
2024-02-07
“[...] the results of the studies presented in this review will hopefully provide the impetus for conducting additional preclinical and clinical studies to evaluate RUX in the setting of MM as well as other types of cancer.” BUFFALO, NY- February 7, 2024 – A new research perspective was published in Oncotarget's Volume 15 on February 5, 2024, entitled, “Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma.” In this new paper, researchers Ashley Del Dosso, Elizabeth Tadevosyan, and James ...

Blood thinners added to clot-busting medication did not improve stroke outcomes

2024-02-07
Research Highlights: Although giving blood thinners along with clot-busting medication may help in treating heart attacks, it did not improve 90-day outcomes in people with clot-caused strokes. Enrollment in a large clinical trial, which had been planned to include more than 1,200 patients with ischemic stroke (clot-caused stroke), was halted after an independent data and safety monitoring board found no indication of benefit among the first 500 patients. The data analysis for the 500 enrolled participants found giving blood thinners along with clot-busting medication did not increase the risk of bleeding into the brain. Embargoed ...

Reinforcing the diverse ways people access seafood can ensure healthy communities in the face of change

Reinforcing the diverse ways people access seafood can ensure healthy communities in the face of change
2024-02-07
(Santa Barbara, Calif.) — As climate change affects the oceans, coastal communities, particularly those at the front lines of ocean warming and sea level rise, are facing pressures that could threaten their access to aquatic foods. “Climate change and other economic shocks are impacting how people access seafood, and typically households that are most reliant on seafood, such as those in Pacific Island countries, are most at risk,” said Jacob Eurich, a research associate at UC Santa Barbara’s Marine Science Institute, and a fisheries scientist at the Environmental Defense Fund. Which is why, he added, it is necessary to increase food system resilience in the area, ...

Non-white victims of lethal violence and suicide in the US die significantly younger than their white counterparts

Non-white victims of lethal violence and suicide in the US die significantly younger than their white counterparts
2024-02-07
In the US, people of color who are killed by violence or die by suicide lose more potential years of life than white victims, according to a new study, which also explored factors that may contribute to these disparities. Gregory Zimmerman of Northeastern University in Boston, US, and colleagues present these findings in the open-access journal PLOS ONE on February 7, 2024. Mounting evidence suggests that, among victims of violence in the US, the average number of potential years of life lost—how much longer the victim would have lived if they survived—is greater for people of color than for white people. To deepen understanding, Zimmerman ...

LAST 30 PRESS RELEASES:

New and improved drug delivery molecules for skeletal muscle

UC San Diego Health ends negotiations with Tri-City Medical Center Healthcare District

MLB add lifesavers to the chain of survival in New York City

ISU studies explore win-win potential of grass-powered energy production

Study identifies biomarker that could predict whether colon cancer patients benefit from chemotherapy

Children are less likely to have type 1 diabetes if their mother has the condition than if their father is affected

Two shark species documented in Puget Sound for first time by Oregon State researchers

AI method radically speeds predictions of materials’ thermal properties

Study: When allocating scarce resources with AI, randomization can improve fairness

Wencai Liu earns 2024 IUPAP Early Career Scientist Prize in Mathematical Physics

Outsourcing conservation in Africa

Study finds big disparities in stroke services across the US

Media Tip Sheet: Urban Ecology at #ESA2024

Michigan Plasma prize honors University of Illinois professor

Atomic 'GPS' elucidates movement during ultrafast material transitions

UMBC scientists work to build “wind-up” sensors

Researchers receive McKnight award to study the evolution of deadly brain cancer

Heather Dyer selected as the 2024 ESA Regional Policy Award Winner

New study disputes Hunga Tonga volcano’s role in 2023-24 global warm-up

Climate is most important factor in where mammals choose to live, study finds

New study highlights global disparities in activity limitations and assistive device use

Study finds targeting inflammation may not help reduce liver fibrosis in MAFLD

Meet Insilico in Singapore: Alex Zhavoronkov PhD shares insights into various aspects of AI-powered drug discovery

Insilico Medicine introduces Science42: DORA, the intelligent writing assistant for accelerated research

A deep dive into polyimides for high-frequency wireless telecommunications

Green hydrogen from direct seawater electrolysis- experts warn against hype

Thousands of birds and fish threatened by mining for clean energy transition

Medical and educational indebtedness among health care workers

US state restrictions and excess COVID-19 pandemic deaths

Posttraumatic stress disorder among adults in communities with mass violence incidents

[Press-News.org] The Medical University of South Carolina will be one of four sites exploring the genetic basis of Parkinson’s disease in the Black community